SAFit2 is a highly potent and selective antagonist of FK506-binding protein 51 (FKBP51) with a Ki of 6 nM. It exhibits anxiolytic and antidepressant-like effects, regulates AKT2-AS160 signaling and metabolic function, and may be useful in research on stress-related disorders and type 2 diabetes.

SAFit2 is a highly potent and selective antagonist of FK506-binding protein 51 (FKBP51) with a Ki of 6 nM. It exhibits anxiolytic and antidepressant-like effects, regulates AKT2-AS160 signaling and metabolic function, and may be useful in research on stress-related disorders and type 2 diabetes.

SAFit2 is a highly potent and selective antagonist of FK506-binding protein 51 (FKBP51) with a Ki of 6 nM. It exhibits anxiolytic and antidepressant-like effects, regulates AKT2-AS160 signaling and metabolic function, and may be useful in research on stress-related disorders and type 2 diabetes.

SAFit2 is a highly potent and selective antagonist of FK506-binding protein 51 (FKBP51) with a Ki of 6 nM. It exhibits anxiolytic and antidepressant-like effects, regulates AKT2-AS160 signaling and metabolic function, and may be useful in research on stress-related disorders and type 2 diabetes.